[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

“Special Measures “- The NHS Trust Development Authority (TDA) – Monitor-CQC

by Jackie (née Heneghan) Peck | May 10, 2014 | Blog, Community Pharmacy, Regulation

What are special measures and how do NHS TDA Monitor and CQC work together? What will happen when NHS TDA and Monitor place a trust in “Special measures”? CQC, through their chief inspector may recommend that a Trust is placed in special measures if they have evidence...

2014 GPhC Inspections – are you prepared?

by Jackie (née Heneghan) Peck | May 2, 2014 | Blog, Community Pharmacy, Pharmacy Brands

It seems 2014 will be the year of GPhC inspections for many pharmacies across the UK.  Many of you may have impending inspections with many more to follow. We’ve had a number of pharmacists contact us recently about the inspection process, what to expect and...

Opening a Pharmacy in 2014

by Jackie (née Heneghan) Peck | May 1, 2014 | Blog, Community Pharmacy

So you want to open a pharmacy? To be your own boss. Do you know which location you would like? Which rule will you apply under? Have you read the relevant PNA? And what does it say? An NHS contracted pharmacy cannot simply be opened; you have to apply.  And you have...

Changing landscape of UK Community Pharmacy

by Jackie (née Heneghan) Peck | Apr 25, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

Following on from news of the Co-Op’s decision to sell of its 750 pharmacies, Chemist & Druggist reported that a private consortium has raised approximately £40 m of the targeted £60 m required to commence their negotiations with the group. Whilst the group...

Falsified Medicines

by Jackie (née Heneghan) Peck | Apr 25, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

As advisors to medicine wholesalers and pharmacies, we concern ourselves with maintaining the integrity of the supply chain.  We stress the importance of being wary of falsified medicines and the pitfalls to look out for. Why is this product so cheap? Why is such a...
« Older Entries
Next Entries »

Recent Posts

  • What are the main requirements for controlled drugs?
  • FSN for Zoll Powerheart G5 AEDs
  • Virtual Wholesaling

Upcoming Courses

  • RP Forum – Inspection Preparation and RP Readiness on 8 July 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 15 July 2025
  • GDP Audit Online Training on 17 July 2025 10:00 am
  • Introduction to Good Distribution Practice Online Training on 23 July 2025 10:00 am
  • Export Online Training on 7 August 2025

MHRA Alerts & Recalls

Class 4 Medicines Defect Notification: Simvastatin 10mg Tablet, Crescent Pharma Ltd, EL(25)A/33
3 July 2025
Field Safety Notices: 23 to 27 June 2025
2 July 2025
Aurum pre-filled syringes phased introduction of new 10ml CONNECT syringe barrel: Importance of selecting compatible needle-free connectors to minimise the risk of syringe blockage (DSI/2025/02)
1 July 2025
Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd, EL(25)A/32
1 July 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow